Bank of America
AVNR

Bank of America’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bank of America’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,700
Closed -$198K – 8113
2014
Q4 		$198K Sell
11,700
-125,700
-91% -$1.77M ﹤0.01% 5379
2014
Q3 		$1.64M Buy
137,400
+121,700
+775% +$831K ﹤0.01% 3563
2014
Q2 		$89K Sell
15,700
-1,500
-9% -$6.91K ﹤0.01% 6228
2014
Q1 		$63K Sell
17,200
-4,400
-20% -$16.8K ﹤0.01% 6297
2013
Q4 		$73K Sell
21,600
-12,600
-37% -$52K ﹤0.01% 6344
2013
Q3 		$145K Buy
34,200
+24,800
+264% +$118K ﹤0.01% 5718
2013
Q2 		$43K Buy
+9,400
New +$32.3K ﹤0.01% 6655

Bank of America's AVNR Position: Q1 2015 in Review

Bank of America sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 19,451 shares — an estimated $330K sold.

Bank of America first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $1.24M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Bank of America reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Bank of America sold 19,451 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $330K.
  • Bank of America first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Bank of America's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.24M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.